openPR Logo
Press release

Constipation Treatment Market Forecast Report Offers Actionable Insights 2017 - 2025

01-05-2018 12:33 PM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Constipation Treatment Market Forecast Report Offers

A large number of player are taking part in the global constipation treatment market, which a very common disorder seen amongst people since long time. With increasing activities of research and development and with the help of latest treatment processes and drugs, the key players in the global market are aiming to bring maximum relief to the patients, and thus has led to the opening up of numerous lucrative opportunities for them. Some of the key players in the global market for constipation treatment include names such as Bayer AG, Sucampo Pharmaceuticals Inc., Takeda Pharmaceuticals Company Limited, Ironwood Pharmaceuticals, Inc., aleant Pharmaceuticals International, Inc., Synergy Pharmaceuticals, Inc., Ironwood Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Abbott Laboratories, AstraZeneca, Daewoong Pharmaceuticals Co. Ltd., Prestige Brands Holdings, Inc., Cosmo Pharmaceuticals NV, Janssen Pharmaceutical Company, Albireo Pharma, Inc., and Shionogi & Co., Ltd., Renexxion, LLC among others.

Browse Premium Industry Research Report with Analysis: https://www.transparencymarketresearch.com/constipation-treatment-market.html

The global market for constipation treatment was valued at US$12.58 bn in the year 2016. This valuation was expected to grow and reach an overall figure worth US$22.93 bn by the end of 2025. This growth of the global market is expected to be achieved with the help of a strong CAGR of 7.1% over the course of the given forecast period of 2017 to 2025. Depend of the therapeutic alternatives, the global market for constipation treatment generates maximum demand for the segment of laxative, which can be further sub-segmented into osmotic laxatives, stimulant laxatives, and bulk forming agents. The segment of laxative is projected to witness an incremental demand at an impressive CAGR of 7.0% over the course of the given forecast period of 2017 to 205, thanks to the low prices and easy availability.

Depending on the type of disease, the global market for constipation treatment has been dominated by the segment of opioid induced constipation, while hospitals are expected to continue their dominance as the most important channel of distribution. In terms of geography, North America is the most lucrative market, though Asia Pacific is expected to show most promising growth rate and generate numerous business opportunities.

Request for Sample Copy of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16442

Constipation is a very common disorder amongst masses, and is experienced by nearly each individual at some stage of their life, if not regularly, and it is evident in a range of 8% to 32.5% of populace across the world. The choice of treatment or medicine depends on the constipation type. One of the key factors responsible for the overall growth of the global constipation treatment market is the growing population of older people across the world. In addition to this, constantly changing dietary habits is also seen to be another important driving factor for the growth of the market. It is projected the over half of the people above the age of 50 are vulnerable to have chronic constipation. Furthermore, leading players in the industry are investing heavily on the development of new treatment drugs for constipation, which is expected to fuel the overall growth of the market.

However, there are some factors that might impede the growth of the global market in the coming years of forecast period. One of the key restraining factor is considered to be the consistent reliance on over the counter (OTC) drugs and on generic laxatives as well. Moreover, the specialty constipation drugs have not yet reached all over the world as expected. This is also expected to slow down the growth of the market.

Purchase this Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=16442<ype=S

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Constipation Treatment Market Forecast Report Offers Actionable Insights 2017 - 2025 here

News-ID: 887098 • Views:

More Releases from Transparency Market Research

Global Avocado-based Products Industry Valued at USD 2.5 Billion in 2024; Projected to Reach USD 5.4 Billion by 2035, Expanding at a CAGR of 6.2%
Global Avocado-based Products Industry Valued at USD 2.5 Billion in 2024; Projec …
The global avocado-based products market(https://www.transparencymarketresearch.com/avocado-based-products-market.html) is gaining strong traction owing to increasing consumer awareness about the health benefits of plant-based and natural foods, coupled with significant advancements in food processing technologies. As per industry estimates, the market was valued at US$ 2.5 Bn in 2024 and is projected to grow at a CAGR of 6.2% from 2025 to 2035, to cross US$ 5.4 Bn by the end of 2035. Discover Market
Warehouse Robotics Market Size to Surpass USD 61.8 Billion by 2035 | Growth Fueled by AI, Vision Systems, and Contactless Automation Across Global E-Commerce and Supply Chains
Warehouse Robotics Market Size to Surpass USD 61.8 Billion by 2035 | Growth Fuel …
The global warehouse robotics market (https://www.transparencymarketresearch.com/warehouse-robotics-market.html) is entering a transformative decade, fueled by the accelerating adoption of automation technologies across logistics, retail, and manufacturing sectors. Valued at US$ 11.6 billion in 2024, the market is projected to grow at a CAGR of 13.8% between 2025 and 2035, reaching a staggering US$ 61.8 billion by 2035. This remarkable growth is driven by rising e-commerce activities, labor shortages, advancements in artificial intelligence (AI),
Global Manufacturing Execution System (MES) Market to Surpass US$ 51.2 Bn by 2035 | Transparency Market Research
Global Manufacturing Execution System (MES) Market to Surpass US$ 51.2 Bn by 203 …
The global Manufacturing Execution System (MES) market is set to experience robust expansion in the coming decade, reflecting the ongoing digital transformation across industries. Valued at US$ 16.9 billion in 2024, the MES market is projected to grow at a CAGR of 10.6% from 2025 to 2035, reaching approximately US$ 51.2 billion by 2035, according to the latest industry analysis. Manufacturing Execution Systems (MES) are increasingly becoming the digital backbone of
HVAC Chillers Market Outlook 2035: Energy-Efficient Cooling Systems Driving Steady 5% CAGR Growth | TMR
HVAC Chillers Market Outlook 2035: Energy-Efficient Cooling Systems Driving Stea …
The global HVAC chillers market is on a robust growth trajectory, powered by the world's increasing emphasis on energy efficiency, sustainability, and the modernization of infrastructure. According to recent market intelligence, the HVAC chillers industry, valued at US$ 13.5 billion in 2024, is projected to grow at a compound annual growth rate (CAGR) of 5.0% between 2025 and 2035, reaching approximately US$ 23.2 billion by the end of 2035. This upward

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the